Drawing for MDT

USPTO serial 77703531

MDT

Reviewed by CopyMark Law Group

Reg. 4346997Status 710
Filing date
Status date
Registration date
Jun 4, 2013
Examiner
BELLO, ZACK
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MDT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Norman P. Soloway

NORMAN P SOLOWAY HAYES SOLOWAY PC4640 E SKYLINE DRIVETUCSON, AZ 85718UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Capsules sold empty for vitamins, pharmaceuticals and supplements, and capsules containing two or more vitamins, pharmaceuticals and veterinary preparations, inhalers filled with pharmaceutical preparations; pharmaceutical preparations, namely, drug delivery systems comprising oral capsules, pills, caplets and tablets for release of therapeutic agents; capsules, pills, caplets and tablets sold with therapeutic agentsSECTION 8 - CANCELLEDApr 27, 2009
007Pharmaceutical agent packaging machinesSECTION 8 - CANCELLEDApr 27, 2009
010Medical devices, namely, drug delivery system comprising oral capsules, pills, caplets and tablets for release of therapeutic agents; medical apparatus for inhalation of pharmaceutical preparations, namely, inhalers and nebulizers; medical apparatus for introducing pharmaceutical preparations into the human body for therapeutic use; drug delivery devices, namely, capsules, pills, caplets and tabletsSECTION 8 - CANCELLEDApr 27, 2009
042Housemark for the design, development and testing of new pharmaceutical and pharmaceutical delivery products for others in the health care and nutritional fieldsSECTION 8 - CANCELLEDApr 27, 2009

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 10, 2020C8..CANCELLED SEC. 8 (6-YR)—
Jun 4, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 3, 2013SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED—
May 2, 2013REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
May 1, 2013CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 3, 2013ACECAMENDMENT FROM APPLICANT ENTERED—
Apr 3, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 27, 2013ALIEASSIGNED TO LIE—
Mar 25, 2013MAILPAPER RECEIVED—
Mar 14, 2013CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2013CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 15, 2013SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 13, 2013AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 28, 2013IUAFUSE AMENDMENT FILED—
Jan 28, 2013EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 31, 2012NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 19, 2012TMBNTTAB RELEASE CASE TO TRADEMARKS—
Jun 19, 2012OP.TOPPOSITION TERMINATED NO. 999999—
Jun 19, 2012OP.DOPPOSITION DISMISSED NO. 999999—
Jun 11, 2012MAILPAPER RECEIVED—
Jun 5, 2012MAILPAPER RECEIVED—
Oct 20, 2011FAXXFAX RECEIVED—
Aug 19, 2011TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 30, 2009OP.IOPPOSITION INSTITUTED NO. 999999—
Sep 1, 2009ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Aug 4, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 15, 2009NPUBNOTICE OF PUBLICATION—
Jun 26, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 26, 2009ALIEASSIGNED TO LIE—
Jun 21, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 15, 2009DOCKASSIGNED TO EXAMINER—
Apr 15, 2009ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 4, 2009MDSMNOTICE OF DESIGN SEARCH CODE MAILED—
Apr 3, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 3, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance